Leventhal Quoted on Court’s Reversal of Reduction in Medi-Cal Outpatient Rates
August 7, 2017
San Francisco Chronicle
Partner Robert Leventhal was quoted in a San Francisco Chronicle article, “SF Court Reverses Approval on Lowered Medi-Cal Outpatient Rates,” covering a 9th U.S. Circuit Court of Appeals decision overturning a reduction in Medi-Cal reimbursement rates to California hospitals for outpatient services during the recession.
Leventhal, who represented 57 hospitals in a challenge to the temporary rate reduction, said the ruling could affect future Medi-Cal payments as well.
“This case sets a standard for what has to be taken into account” in setting payment levels to hospitals for outpatient services for Medi-Cal patients, he said.
Leventhal, who represented 57 hospitals in a challenge to the temporary rate reduction, said the ruling could affect future Medi-Cal payments as well.
“This case sets a standard for what has to be taken into account” in setting payment levels to hospitals for outpatient services for Medi-Cal patients, he said.
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."